{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:24:16Z","timestamp":1785936256801,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"],"award-info":[{"award-number":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"],"award-info":[{"award-number":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"],"award-info":[{"award-number":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"],"award-info":[{"award-number":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"],"award-info":[{"award-number":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"],"award-info":[{"award-number":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"],"award-info":[{"award-number":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"],"award-info":[{"award-number":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"],"award-info":[{"award-number":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"],"award-info":[{"award-number":["H19\/01\/a0\/023 \u2013 Diabetes Clinic of the Future"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-024-01230-5","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T13:28:20Z","timestamp":1726666100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A drug mix and dose decision algorithm for individualized type 2 diabetes management"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9445-6516","authenticated-orcid":false,"given":"Mila","family":"Nambiar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5482-2646","authenticated-orcid":false,"given":"Yong Mong","family":"Bee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu En","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Ho Mien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feri","family":"Guretno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Carmody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phong Ching","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-3141","authenticated-orcid":false,"given":"Sing Yi","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Nasyitah Mohamed","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-4306","authenticated-orcid":false,"given":"Pavitra","family":"Krishnaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"1230_CR1","unstructured":"Melmed, S., Koenig, R., Rosen, C., Auchus, R. & Goldfine, A. Williams Textbook of Endocrinology - 14th Edition (Elsevier, 2019)."},{"key":"1230_CR2","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes\u20142021. Diabetes Care 44, S111\u2013S124 (2021).","DOI":"10.2337\/dc21-S009"},{"key":"1230_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2337\/dci19-0066","volume":"43","author":"JB Buse","year":"2019","unstructured":"Buse, J. B. et al. 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 43, 487\u2013493 (2019).","journal-title":"Diabetes Care"},{"key":"1230_CR4","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.2337\/dc12-0413","volume":"35","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi, S. E. et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35, 1364\u20131379 (2012).","journal-title":"Diabetes Care"},{"key":"1230_CR5","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2337\/dc13-0512","volume":"36","author":"I Raz","year":"2013","unstructured":"Raz, I. et al. Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors\u2019 Expert Forum. Diabetes Care 36, 1779\u20131788 (2013).","journal-title":"Diabetes Care"},{"key":"1230_CR6","doi-asserted-by":"crossref","unstructured":"Gimeno, J. A., C\u00e1novas, G. & Dur\u00e1n, A. Factors associated with adherence to clinical practice guidelines for patients with type 2 diabetes mellitus: results of a Spanish Delphi Consensus. J. Diabetes Res. 9970859 (2021).","DOI":"10.1155\/2021\/9970859"},{"key":"1230_CR7","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1001\/jama.2010.405","volume":"303","author":"OJ Phung","year":"2010","unstructured":"Phung, O. J., Scholle, J. M., Talwar, M. & Coleman, C. I. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA 303, 1410\u20131418 (2010).","journal-title":"JAMA"},{"key":"1230_CR8","doi-asserted-by":"publisher","first-page":"854","DOI":"10.7326\/0003-4819-151-12-200912150-00005","volume":"151","author":"S Greenfield","year":"2009","unstructured":"Greenfield, S. et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann. Intern. Med. 151, 854\u2013860 (2009).","journal-title":"Ann. Intern. Med."},{"key":"1230_CR9","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","volume":"52","author":"FM Turnbull","year":"2009","unstructured":"Turnbull, F. M. et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 52, 2288\u20132298 (2009).","journal-title":"Diabetologia"},{"key":"1230_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","volume":"7","author":"JM Dennis","year":"2019","unstructured":"Dennis, J. M., Shields, B. M., Henley, W. E., Jones, A. G. & Hattersley, A. T. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 7, 442\u2013451 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1230_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2011.02.002","volume":"93","author":"S Nam","year":"2011","unstructured":"Nam, S., Chesla, C., Stotts, N. A., Kroon, L. & Janson, S. L. Barriers to diabetes management: patient and provider factors. Diabetes Res. Clin. Pr. 93, 1\u20139 (2011).","journal-title":"Diabetes Res. Clin. Pr."},{"key":"1230_CR12","doi-asserted-by":"publisher","first-page":"600","DOI":"10.2337\/diacare.28.3.600","volume":"28","author":"BR Shah","year":"2005","unstructured":"Shah, B. R., Hux, J. E., Laupacis, A., Zinman, B. & van Walraven, C. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care 28, 600\u2013606 (2005).","journal-title":"Diabetes Care"},{"key":"1230_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/dme.12592","volume":"32","author":"A Zafar","year":"2015","unstructured":"Zafar, A., Stone, M. A., Davies, M. J. & Khunti, K. Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care: a qualitative study. Diabet. Med. 32, 407\u2013413 (2015).","journal-title":"Diabet. Med."},{"key":"1230_CR14","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.3399\/bjgp16X683509","volume":"66","author":"B Rushforth","year":"2016","unstructured":"Rushforth, B., McCrorie, C., Glidewell, L., Midgley, E. & Foy, R. Barriers to effective management of type 2 diabetes in primary care: qualitative systematic review. Br. J. Gen. Pr. 66, e114\u2013e127 (2016).","journal-title":"Br. J. Gen. Pr."},{"key":"1230_CR15","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.2337\/dc13-0331","volume":"36","author":"K Khunti","year":"2013","unstructured":"Khunti, K., Wolden, M. L., Thorsted, B. L., Andersen, M. & Davies, M. J. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care 36, 3411\u20133417 (2013).","journal-title":"Diabetes Care"},{"key":"1230_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/1479164116679775","volume":"14","author":"L Blonde","year":"2017","unstructured":"Blonde, L. et al. Gaps and barriers in the control of blood glucose in people with type 2 diabetes. Diab Vasc. Dis. Res. 14, 172\u2013183 (2017).","journal-title":"Diab Vasc. Dis. Res."},{"key":"1230_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2337\/dc16-0826","volume":"40","author":"D Bertsimas","year":"2017","unstructured":"Bertsimas, D., Kallus, N., Weinstein, A. M. & Zhuo, Y. D. Personalized diabetes management using electronic medical records. Diabetes Care 40, 210\u2013217 (2017).","journal-title":"Diabetes Care"},{"key":"1230_CR18","doi-asserted-by":"publisher","first-page":"e27858","DOI":"10.2196\/27858","volume":"23","author":"X Sun","year":"2021","unstructured":"Sun, X. et al. Effective treatment recommendations for type 2 diabetes management using reinforcement learning: treatment recommendation model development and validation. J. Med. Internet Res. 23, e27858 (2021).","journal-title":"J. Med. Internet Res."},{"key":"1230_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86419-4","volume":"11","author":"S-H Oh","year":"2021","unstructured":"Oh, S.-H., Lee, S. J., Noh, J. & Mo, J. Optimal treatment recommendations for diabetes patients using the Markov decision process along with the South Korean electronic health records. Sci. Rep. 11, 6920 (2021).","journal-title":"Sci. Rep."},{"key":"1230_CR20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s40265-020-01435-4","volume":"81","author":"H Zheng","year":"2021","unstructured":"Zheng, H., Ryzhov, I. O., Xie, W. & Zhong, J. Personalized multimorbidity management for patients with type 2 diabetes using reinforcement learning of electronic health records. Drugs 81, 471\u2013482 (2021).","journal-title":"Drugs"},{"key":"1230_CR21","doi-asserted-by":"crossref","unstructured":"Nambiar, M. et al. Deep offline reinforcement learning for real-world treatment optimization applications. In Proceedings of the 29th ACM SIGKDD Conference on Knowledge Discovery and Data Mining. 4673\u20134684 (Association for Computing Machinery, 2023).","DOI":"10.1145\/3580305.3599800"},{"key":"1230_CR22","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/CIRCULATIONAHA.114.010389","volume":"130","author":"BM Scirica","year":"2014","unstructured":"Scirica, B. M. et al. Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial. Circulation 130, 1579\u20131588 (2014).","journal-title":"Circulation"},{"key":"1230_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1161\/CIRCULATIONAHA.118.038352","volume":"139","author":"DK McGuire","year":"2019","unstructured":"McGuire, D. K. et al. Linagliptin effects on heart failure and related outcomes in individuals with type 2 diabetes mellitus at high cardiovascular and renal risk in CARMELINA. Circulation 139, 351\u2013361 (2019).","journal-title":"Circulation"},{"key":"1230_CR24","doi-asserted-by":"publisher","first-page":"d1309","DOI":"10.1136\/bmj.d1309","volume":"342","author":"YK Loke","year":"2011","unstructured":"Loke, Y. K., Kwok, C. S. & Singh, S. Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies. BMJ 342, d1309 (2011).","journal-title":"BMJ"},{"key":"1230_CR25","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2215\/CJN.05150418","volume":"13","author":"DM Roberts","year":"2018","unstructured":"Roberts, D. M., Sevastos, J., Carland, J. E., Stocker, S. L. & Lea-Henry, T. N. Clinical pharmacokinetics in kidney disease: application to rational design of dosing regimens. Clin. J. Am. Soc. Nephrol. 13, 1254\u20131263 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1230_CR26","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/jdi.12755","volume":"9","author":"K Kanto","year":"2017","unstructured":"Kanto, K. et al. Effects of dosage and dosing frequency on the efficacy and safety of high-dose metformin in Japanese patients with type 2 diabetes mellitus. J. Diabetes Investig. 9, 587\u2013593 (2017).","journal-title":"J. Diabetes Investig."},{"key":"1230_CR27","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s13300-021-01034-w","volume":"12","author":"B Chubb","year":"2021","unstructured":"Chubb, B. et al. Once-daily oral semaglutide versus injectable GLP-1 RAs in people with type 2 diabetes inadequately controlled on basal insulin: systematic review and network meta-analysis. Diabetes Ther. 12, 1325\u20131339 (2021).","journal-title":"Diabetes Ther."},{"key":"1230_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1503\/cmaj.050748","volume":"174","author":"SH Simpson","year":"2006","unstructured":"Simpson, S. H., Majumdar, S. R., Tsuyuki, R. T., Eurich, D. T. & Johnson, J. A. Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study. CMAJ 174, 169\u2013174 (2006).","journal-title":"CMAJ"},{"key":"1230_CR29","doi-asserted-by":"crossref","unstructured":"Lim, D. Y. Z., Chia, S. Y., Abdul Kadir, H., Mohamed Salim, N. N. & Bee, Y. M. Establishment of the SingHealth Diabetes Registry. Clin. Epidemiol. 13, 215\u2013223 (2021).","DOI":"10.2147\/CLEP.S300663"},{"key":"1230_CR30","unstructured":"MIMS Singapore. \u2018antidiabetic agents\u2019 Drug Search. https:\/\/www.mims.com\/singapore\/drug\/search?q=antidiabetic+agents&code=11b (2021)."},{"key":"1230_CR31","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.pec.2017.06.030","volume":"100","author":"M Saheb Kashaf","year":"2017","unstructured":"Saheb Kashaf, M., McGill, E. T. & Berger, Z. D. Shared decision-making and outcomes in type 2 diabetes: a systematic review and meta-analysis. Patient Educ. Couns. 100, 2159\u20132171 (2017).","journal-title":"Patient Educ. Couns."},{"key":"1230_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11892-015-0688-0","volume":"15","author":"S Tamhane","year":"2015","unstructured":"Tamhane, S., Rodriguez-Gutierrez, R., Hargraves, I. & Montori, V. M. Shared decision-making in diabetes care. Curr. Diab Rep. 15, 112 (2015).","journal-title":"Curr. Diab Rep."},{"key":"1230_CR33","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"SPRINT Research Group","year":"2015","unstructured":"SPRINT Research Group et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373, 2103\u20132116 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1230_CR34","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1001\/jama.2023.2487","volume":"329","author":"S-J Hong","year":"2023","unstructured":"Hong, S.-J. et al. Treat-to-target or high-intensity statin in patients with coronary artery disease: a randomized clinical trial. JAMA 329, 1078\u20131087 (2023).","journal-title":"JAMA"},{"key":"1230_CR35","volume":"10","author":"S Raghavan","year":"2017","unstructured":"Raghavan, S. & Matlock, D. Diabetes mellitus treatment deintensification: when well-controlled diabetes mellitus becomes overcontrolled. Circ: Cardiovasc. Qual. Outcomes 10, e003706 (2017).","journal-title":"Circ: Cardiovasc. Qual. Outcomes"},{"key":"1230_CR36","doi-asserted-by":"publisher","unstructured":"Arnab, R. Chapter 7 - Stratified sampling. in Survey Sampling Theory and Applications (ed. Arnab, R.) 213\u2013256 https:\/\/doi.org\/10.1016\/B978-0-12-811848-1.00007-8 (Academic Press, 2017).","DOI":"10.1016\/B978-0-12-811848-1.00007-8"},{"key":"1230_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2337\/diaspect.27.2.87","volume":"27","author":"S Subramanian","year":"2014","unstructured":"Subramanian, S. & Hirsch, I. B. Personalized diabetes management: moving from algorithmic to individualized therapy. Diabetes Spectr. 27, 87\u201391 (2014).","journal-title":"Diabetes Spectr."},{"key":"1230_CR38","unstructured":"Agency for Care Effectiveness, Ministry of Health, Republic of Singapore. Appropriate care guide (ACG): oral glucose-lowering agents in type 2 diabetes mellitus\u2014an update. https:\/\/www.ace-hta.gov.sg\/healthcare-professionals\/ace-clinical-guidances-(acgs)\/details\/t2dm-personalising-medications (2017)."},{"key":"1230_CR39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani, R. Regression shrinkage and selection via the Lasso. J. R. Stat. Soc. Ser. B 58, 267\u2013288 (1996).","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"1230_CR40","doi-asserted-by":"crossref","unstructured":"Chen, T. & Guestrin, C. XGBoost: a scalable tree boosting system. in Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining 785\u2013794 (Association for Computing Machinery, 2016).","DOI":"10.1145\/2939672.2939785"},{"key":"1230_CR41","doi-asserted-by":"publisher","first-page":"626766","DOI":"10.3389\/fphar.2021.626766","volume":"12","author":"JV Koomen","year":"2021","unstructured":"Koomen, J. V., Stevens, J., Monster-Simons, M. H., Heerspink, H. J. L. & Mol, P. G. M. A review of the dose justification of phase 3 trials to regulatory authorities for drugs intended for the treatment of type 2 diabetes in Europe. Front. Pharmacol. 12, 626766 (2021).","journal-title":"Front. Pharmacol."},{"key":"1230_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/00401706.1995.10484303","volume":"37","author":"T Hesterberg","year":"1995","unstructured":"Hesterberg, T. Weighted average importance sampling and defensive mixture distributions. Technometrics 37, 185\u2013194 (1995).","journal-title":"Technometrics"},{"key":"1230_CR43","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/s41591-018-0213-5","volume":"24","author":"M Komorowski","year":"2018","unstructured":"Komorowski, M., Celi, L. A., Badawi, O., Gordon, A. C. & Faisal, A. A. The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care. Nat. Med. 24, 1716\u20131720 (2018).","journal-title":"Nat. Med."},{"key":"1230_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2020.102003","volume":"112","author":"L Roggeveen","year":"2021","unstructured":"Roggeveen, L. et al. Transatlantic transferability of a new reinforcement learning model for optimizing haemodynamic treatment for critically ill patients with sepsis. Artif. Intell. Med. 112, 102003 (2021).","journal-title":"Artif. Intell. Med."},{"key":"1230_CR45","unstructured":"Raghu, A., Komorowski, M., Celi, L.A., Szolovits, P. & Ghassemi, M. Continuous state-space models for optimal sepsis treatment: A deep reinforcement learning approach. In Proceedings of the 2nd Machine Learning for Healthcare Conference. Vol. 68 (eds Doshi-Velez, F. et al) 147\u2013163 (PMLR, 2017)."},{"key":"1230_CR46","unstructured":"Moore, D. S. The Basic Practice of Statistics (W.H. Freeman, 2004)."},{"key":"1230_CR47","doi-asserted-by":"crossref","unstructured":"Pope, C. & Mays, N. Qualitative Research in Health Care, 4th Edition (Wiley-Blackwelltes, 2020).","DOI":"10.1002\/9781119410867"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01230-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01230-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01230-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T16:05:51Z","timestamp":1726848351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01230-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1230"],"URL":"https:\/\/doi.org\/10.1038\/s41746-024-01230-5","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"23 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"254"}}